Loading...
Loading...
By Sofía Garduño - Tue, 03/10/2026 - 10:20
BioNTech founders will launch a new mRNA biotech company as the firm focuses on late-stage oncology trials and prepares for a leadership transition.
Featured content
Mon, 01/05/2026 - 08:30
Scaling functional medicine in Mexico requires ecosystem models and precision health to fight chronic disease, writes Gustavo Rodríguez.
https://mexicobusiness.news/tag/clinical-trials
More Health
By Aura Moreno - Mon, 03/02/2026 - 08:50
Lilly’s oral GLP-1 orforglipron surpassed semaglutide in A1C reduction and weight loss, reshaping the oral cardiometabolic market.
By Aura Moreno - Thu, 02/26/2026 - 14:41
The FDA’s qualification of hip bone mineral density as a surrogate endpoint is expected to reshape osteoporosis drug development.
By Sofía Garduño - Wed, 02/25/2026 - 15:57
Bristol has led research in Mexico for 80 years, making it central to its mission, says Oswaldo Bernal, General Manager, Bristol Myers Squibb.
By Aura Moreno - Thu, 02/19/2026 - 11:13
Biomarkers, sleep, and emerging therapies reveal new insights into Alzheimer’s disease progression and potential interventions.
By Aura Moreno - Fri, 02/06/2026 - 16:21
New oral drugs for cholesterol and diabetes point to a shift toward earlier, less invasive cardiometabolic disease management.
By Luis Alberto Velez - Wed, 01/28/2026 - 06:00
CRISPR-Cas9 enables precise gene editing in oncology, upgrading immune hardware to reprogram and finish cancer, writes Luis Velez.
By Sofía Garduño - Tue, 01/20/2026 - 11:13
Mexico strengthens ethical and regulatory oversight of clinical trials through interinstitutional coordination under Plan México.
By MBN Staff - Wed, 12/31/2025 - 12:16
UNAM researchers developed therapeutic breast cancer vaccines with preclinical success, clearing the path for future human trials.
By Guillaume Corpart - Mon, 12/15/2025 - 06:00
The outlook on cancer, both worldwide and in Latin America, is a complex story that includes both good news and bad news. Guillaume Corpart explains.
